Novel compounds open new research avenues for Alzheimer's disease therapeutics

Alzheimer's disease is the most common cause of dementia, and it affects over 7 million people in the United States alone. Although there are treatments that can slow its progression, most of them treat its symptoms only and none of them can cure the disease.